Polyglandular hyperfunction
ICD-10 E31.1 is a billable code used to indicate a diagnosis of polyglandular hyperfunction.
Polyglandular hyperfunction refers to a condition characterized by the overactivity of multiple endocrine glands, leading to an excess of hormones that can disrupt normal physiological functions. This condition often manifests during puberty, a critical period of growth and development, where hormonal imbalances can significantly impact growth patterns and sexual maturation. The thymus gland, which plays a vital role in immune function and the development of T-cells, may also be affected, leading to potential immunological disorders. Patients may experience symptoms related to hyperthyroidism, hyperparathyroidism, or adrenal hyperfunction, which can include weight loss, increased appetite, anxiety, and abnormal growth rates. The interplay between these glands can complicate diagnosis and management, as symptoms may overlap with other endocrine disorders. Accurate coding and documentation are essential for effective treatment planning and monitoring of growth abnormalities associated with polyglandular hyperfunction.
Detailed hormonal assay results and gland-specific symptoms.
Patients presenting with unexplained weight changes, growth abnormalities, or signs of hyperfunction.
Ensure all relevant endocrine evaluations are documented to support the diagnosis.
Growth charts and developmental milestones must be included.
Adolescents with abnormal growth patterns or delayed puberty.
Consider psychosocial factors affecting growth and development.
Used to evaluate thyroid function in patients with suspected hyperthyroidism.
Document the rationale for testing and any relevant clinical findings.
Endocrinologists should ensure comprehensive thyroid evaluations are performed.
Common symptoms include weight changes, increased appetite, anxiety, fatigue, and abnormal growth patterns, depending on which glands are affected.
